Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.

Jover, J A; Hernández-García, C; Morado, I C; Vargas, E; Bañares, A; Fernández-Gutiérrez, B

Jover, J A; Hernández-García, C; Morado, I C; Vargas, E; Bañares, A; Fernández-Gutiérrez, B.

Affiliation

Jover JA; Servicio de Reumatología, Hospital Clínico San Carlos, Calle Profesor Martín Lagos s/n, 28040 Madrid, Spain. jjover@hcsc.insalud.es

Ann Intern Med ; 134(2): 106-14, 2001 Jan 16.

Article in En | MEDLINE | ID: mdl-11177313

Subject(s)

Adrenal Cortex Hormones/therapeutic use; Giant Cell Arteritis/drug therapy; Immunosuppressive Agents/therapeutic use; Methotrexate/therapeutic use; Prednisone/therapeutic use; Adrenal Cortex Hormones/adverse effects; Aged; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents/administration & dosage; Immunosuppressive Agents/adverse effects; Male; Methotrexate/administration & dosage; Methotrexate/adverse effects; Placebos; Prednisone/administration & dosage; Prednisone/adverse effects; Recurrence; Sensitivity and Specificity; Statistics, Nonparametric

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Giant Cell Arteritis / Prednisone / Methotrexate / Adrenal Cortex Hormones / Immunosuppressive Agents Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: Ann Intern Med Year: 2001 Document type: Article Affiliation country: Spain Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links